
Research and Discovery
We connect organisations with the scientific talent driving early-stage innovation from bench scientists advancing novel mechanisms to research leaders shaping discovery strategy.
As AI-driven target identification and platform technologies reshape early discovery, the scientific leaders who can translate novel mechanisms into de-risked, fundable programmes are in shorter supply than the funding chasing them.
Recent placements:
- Head of Translational Medicine, Mid-size biopharma
- Senior Principal Scientist, Mid-size biopharma
Situation
A mid-size biopharmaceutical company needed a Head of Translational Medicine to bridge a stalled handoff between its discovery and clinical teams on a novel mechanism programme.

Approach
Rather than scanning the market from zero, Execruit drew on its network of translational scientists with direct bench-to-clinic experience, screening candidates for the cross-functional fluency the role specifically demanded.

Outcome
A shortlist was delivered within two weeks; the hire re-aligned the discovery-to-clinic handoff process within her first quarter, and the programme advanced into IND-enabling studies on schedule.
Execruit's view of Research and Discovery searches is shaped by Signe Reidla's Medical Doctor training and her experience carrying a novel antiviral compound from research through to global approval at F. Hoffmann-La Roche AG, giving Execruit a first-hand understanding of what separates promising early science from a programme that can survive the transition into development.

